G

Greg Deener

Io Therapeutics (United States)

Publishes on Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology, Substance Abuse Treatment and Outcomes. 4 papers and 302 citations.

4Publications

302Total Citations

Systemic Lupus Erythematosus Research T-cell and B-cell Immunology Substance Abuse Treatment and Outcomes Smoking Behavior and Cessation Monoclonal and Polyclonal Antibodies Research

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

Weijia Wang, Shanzhi He, Wenli Zhang et al.|Annals of the Rheumatic Diseases|2024

Cited by 184

The effect of bupropion sustained-release on cigarette craving after smoking cessation

Michael J. Durcan, Greg Deener, J. D. White et al.|Clinical Therapeutics|2002

Cited by 110

POS1134 NOVEL APPROACH TO TREAT SYSTEMIC LUPUS ERYTHEMATOSUS, BY TARGETING THE “ROOT CAUSE”, B CELLS AND PLASMA CELLS, USING BCMA-CD19 COMPOUND CAR

Yun Yuan, Shaoheng He, Weidong Zhang et al.|Annals of the Rheumatic Diseases|2023

Cited by 7Open Access

OP0017 BCMA CD19 COMPOUND CHIMERIC ANTIGEN RECEPTOR T CELLS (cCAR) PROVIDES COMPLETE HUMORAL RESET, ELIMINATES ALL ELEVATED AUTOANTIBODIES, IMPROVES SYMPTOMS AND RENAL FUNCTION IN LUPUS NEPHRITIS (LN) PATIENTS

Ying Ma, Ye Yuan, Shunzhi He et al.|Annals of the Rheumatic Diseases|2024

Cited by 3